Virtual Presentation Available on KSI-301 for wAMD, DME, RVO
Source: Pixabay

Virtual Presentation Available on KSI-301 for wAMD, DME, RVO

This past November, nearly 9,000 attendees showed up for the American Academy of Ophthalmology (AAO) 2020 Virtual Annual Meeting. During the meeting, biopharmaceutical company Kodiak Sciences Inc. ("Kodiak") announced that…

Continue Reading Virtual Presentation Available on KSI-301 for wAMD, DME, RVO
Stem Cells Could Cure the Most Common Cause of Irreversible Blindness 
source: pixabay.com

Stem Cells Could Cure the Most Common Cause of Irreversible Blindness 

As reported in Medical Xpress; Fight for Sight, a charity in the UK dedicated to vision, has an exciting announcement for people with macular diseases: they have just granted funding…

Continue Reading Stem Cells Could Cure the Most Common Cause of Irreversible Blindness 
Wet Macular Degeneration: X-82 Clinical Trial Stopped Over Toxicity Issues
Source: Pixabay.com

Wet Macular Degeneration: X-82 Clinical Trial Stopped Over Toxicity Issues

  Over the last few days, the American Society of Retina Specialists (ASRS) held their Annual Virtual Meeting; coined "2020 Virtual Sessions," professionals converged online to share insights into ophthalmological…

Continue Reading Wet Macular Degeneration: X-82 Clinical Trial Stopped Over Toxicity Issues
Safety Reviews of Beovu, a Treatment for Neovascular AMD
bspence81 / Pixabay

Safety Reviews of Beovu, a Treatment for Neovascular AMD

  Despite rigorous testing before pharmaceutical products are introduced to the market, some still present negative side effects. In a discussion on Beovu (brolucizumab), used to treat neovascular macular degeneration…

Continue Reading Safety Reviews of Beovu, a Treatment for Neovascular AMD
Study: Antibody Treatments for Wet Macular Degeneration
https://pixabay.com/en/money-piggy-bank-coins-finance-2180338/

Study: Antibody Treatments for Wet Macular Degeneration

  Unfortunately, there are downsides to a lot of treatments for various diseases, such as price, frequency of doses, and discomfort. Any one of these factors can discourage people from…

Continue Reading Study: Antibody Treatments for Wet Macular Degeneration